NIH Adds Atlanta Site to Clinical Trial of COVID-19 Vaccine

NIH Adds Atlanta Site to Clinical Trial of COVID-19 Vaccine
A researcher works on virus replication in order to develop a vaccine against COVID-19, in Belo Horizonte, Brazil, on March 26, 2020. Douglas Magno/AFP/Getty Images
Tom Ozimek
By Tom Ozimek, Reporter
Updated:

The National Institutes of Health (NIH) said a medical facility in Georgia would be added to the agency’s clinical trial of a vaccine for COVID-19, the disease the CCP virus, commonly known as the novel coronavirus, causes.

The Epoch Times refers to the novel coronavirus, which originated in Wuhan, as the CCP virus because the Chinese Communist Party’s coverup and mismanagement allowed the virus to spread throughout China before it was transmitted worldwide.
Tom Ozimek
Tom Ozimek
Reporter
Tom Ozimek is a senior reporter for The Epoch Times. He has a broad background in journalism, deposit insurance, marketing and communications, and adult education.
twitter
Related Topics